Suppr超能文献

血清谷胱甘肽转移酶对吲哚-3-甲醇没有反应:一项初步研究。

Serum glutathione transferase does not respond to indole-3-carbinol: A pilot study.

机构信息

Ipswich Hospital, Ipswich, UK;

出版信息

Ther Clin Risk Manag. 2010 May 25;6:225-31. doi: 10.2147/tcrm.s9568.

Abstract

BACKGROUND

Despite the well recognized protective effect of cruciferous vegetables against various cancers, including human colorectal cancers, little is known about how this effect is conferred. It is thought that some phytochemicals found only in these vegetables confer the protection. These compounds include the glucosinolates, of which indole-3-carbinol is one. They are known to induce carcinogen-metabolizing (phase II) enzymes, including the glutathione S-transferase (GST) family. Other effects in humans are not well documented. We wished to assess the effect of indole-3-carbinol on GST enzymes.

METHODS

We carried out a placebo-controlled human volunteer study. All patients were given 400 mg daily of indole-3-carbinol for three months, followed by placebo. Serum samples were tested for the GSTM1 genotype by polymerase chain reaction. Serum GST levels were assessed using enzyme-linked immunosorbent assay and Western Blot methodologies.

RESULTS

Forty-nine volunteers completed the study. GSTM1 genotypes were obtained for all but two volunteers. A slightly greater proportion of volunteers were GSTM1-positive, in keeping with the general population. GST was detected in all patients. Total GST level was not affected by indole-3-carbinol dosing compared with placebo. Although not statistically significant, the GSTM1 genotype affected the serum GST level response to indole-3-carbinol.

CONCLUSION

Indole-3-carbinol does not alter total serum GST levels during prolonged dosing.

摘要

背景

尽管十字花科蔬菜对包括人类结直肠癌在内的各种癌症具有明显的保护作用,但人们对此作用的机制知之甚少。人们认为,这些蔬菜中仅有的一些植物化学物质赋予了这种保护作用。这些化合物包括硫代葡萄糖苷,其中吲哚-3-甲醇就是其中之一。已知它们可以诱导致癌物代谢(II 期)酶,包括谷胱甘肽 S-转移酶(GST)家族。其他在人类中的作用尚未得到很好的记录。我们希望评估吲哚-3-甲醇对 GST 酶的影响。

方法

我们进行了一项安慰剂对照的人类志愿者研究。所有患者每天服用 400 毫克吲哚-3-甲醇,持续三个月,然后服用安慰剂。通过聚合酶链反应检测血清样本中的 GSTM1 基因型。使用酶联免疫吸附测定和 Western Blot 方法评估血清 GST 水平。

结果

49 名志愿者完成了研究。除了两名志愿者外,所有人的 GSTM1 基因型均已获得。志愿者中 GSTM1 阳性的比例略高,与一般人群一致。所有患者均检测到 GST。与安慰剂相比,吲哚-3-甲醇给药并未影响总 GST 水平。尽管没有统计学意义,但 GSTM1 基因型影响了血清 GST 对吲哚-3-甲醇的反应。

结论

在长期给药期间,吲哚-3-甲醇不会改变总血清 GST 水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3005/2878956/22be861347f8/tcrm-6-225f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验